A circuit formed by tumor, immune and nervous systems triggers cancer cachexia and anorexia, the excessive loss of weight, muscle and fat experienced in some cancer types. A new study is the first ...

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...

For many families, the most shocking part of a cancer journey is not the tumour itself, but the steady wasting that follows — loss of appetite, falling weight, thinning muscles, and the feeling that ...

A dual cannabinoid agonist drug candidate is being investigated for its potential in treating wasting syndrome in cancer patients. It demonstrated a weight gain in patients who took the drug versus a ...

Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...

ART27.13 shows promise in reversing weight loss and increasing lean body mass in cancer anorexia-cachexia syndrome patients, with a significant difference compared to placebo. The drug's mechanism ...

SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...